Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report
Main Article Content
Abstract
A 62-year-old female patient, in menopause since the age of 47, presented with severe and virilizing hyperandrogenism condition that had been progressing for 10 years, with plasma testosterone levels above 500 ng/dL. Medical history included Cushing 's disease in remission since hypophysectomy in 2014 and obesity. On imaging tests, there was an adenoma in the left adrenal gland with normal ovaries. Serum DHEA-sulfate concentrations, however, were normal and pelvic ultrasound and magnetic resonance imaging showed no ovarian lesions. Given the etiological doubt of hyperandrogenism, ovarian or adrenal, an additional test was necessary. However, serum gonadotropin concentrations were low, preventing testing with a GnRH analogue. A test was carried out with Clomiphene - a selective estrogen receptor modulator that stimulates the secretion of gonadotropins - at a dose of 50 mg/day orally for 5 days. Serum testosterone concentrations increased from 670 ng/dL, pre-use, to 893 ng/dL post-use, suggesting ovarian origin. The patient underwent bilateral oophorectomy and a Leydig cell tumor was confirmed. Therefore, we suggest that in women with hyperandrogenism of undefined origin, with suppressed concentrations of plasma gonadotropins, a clomiphene administration test be performed. The significant increase in plasma testosterone concentrations is indicative of the ovarian origin of the condition.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Polisseni F, et al. Síndrome hiperandrogênica em mulher na pós-menopausa: relato de caso. Ver Bras Ginecol Obstet. 2011;33(8):214-20.
Fernandes S, et al. Hirsutismo pós-menopausa: caso clínico raro de hipertecose ovárica. Reprod Clim. 2015;30(1):42-46.
Filho AC, et al. Tumor ovariano de células de Leydig puro. Rev Bras Cancerol. 2008;54(3):245-250.
Chen MM, Zhou W, Zhang Z, Zou Y, Li C. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report. Medicine (Baltimore). 2018;97(10). doi:10.1097/MD.0000000000010093.
Bužinskienė D, Marčiukaitytė R, Šidlovska E, Rudaitis V. Ovarian Leydig cell tumor and ovarian hyperthecosis in a post-menopausal woman: A case report and literature review. Medicina (Kaunas). 2023;59(6):1097. Published 2023 Jun 6. doi:10.3390/medicina59061097.
Souto SB, Baptista PV, Braga DC, Carvalho D. Ovarian Leydig cell tumor in a post-menopausal patient with severe hype-randrogenism. Arq Bras Endocrinol Metab [Internet]. 2014;58(1):68–75. Available from: https://doi.org/10.1590/0004-2730000002461.
Sherf S, Martinez D. Leydig cell tumor in the post-menopausal woman: case report and literature review. Acta Biomed. 2016;87(3):310-313. Published 2016 Jan 16.
Ferrinho C, et al. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation. BMJ Case Rep. 2021;14.
Suturina LV, et al. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperan-drogenism: A Case Report. Metabolites. 2022;12(620).
Faria AM, et al. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor. Nat Rev Endocrinol. 2011;7:240–245.
Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women. Endocrinol Diabetes Metab Case Rep. 2018;2018:18-0084. doi: 10.1530/EDM-18-0084.
Kaltsas GA, et al. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab. 2003;88(6):2634–2643.
Fanta M, Fischerová D, Indrielle-Kelly T, et al. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series. J Obstet Gynaecol. 2019;39(3):359-364. doi:10.1080/01443615.2018.1517148.
Fracasso LB, Silva NM, Mello TM, et al. Tumor de células de Leydig do ovário associado a virilização em paciente na pós-menopausa. Clin Biomed Res [Internet]. 2016;172–5. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-831743.